These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28386621)

  • 1. Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors.
    De Witt M; Gamble A; Hanson D; Markowitz D; Powell C; Al Dimassi S; Atlas M; Boockvar J; Ruggieri R; Symons M
    Mol Med; 2017 Apr; 23():50-56. PubMed ID: 28386621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.
    Meco D; Attinà G; Mastrangelo S; Navarra P; Ruggiero A
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma.
    Ciesielski MJ; Bu Y; Munich SA; Teegarden P; Smolinski MP; Clements JL; Lau JYN; Hangauer DG; Fenstermaker RA
    J Neurooncol; 2018 Dec; 140(3):519-527. PubMed ID: 30238350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme.
    Bai RY; Staedtke V; Aprhys CM; Gallia GL; Riggins GJ
    Neuro Oncol; 2011 Sep; 13(9):974-82. PubMed ID: 21764822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model.
    Bai RY; Staedtke V; Wanjiku T; Rudek MA; Joshi A; Gallia GL; Riggins GJ
    Clin Cancer Res; 2015 Aug; 21(15):3462-3470. PubMed ID: 25862759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells.
    Wang X; Lou K; Song X; Ma H; Zhou X; Xu H; Wang W
    Toxicol Appl Pharmacol; 2020 Jun; 396():115001. PubMed ID: 32277947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.
    Ariey-Bonnet J; Carrasco K; Le Grand M; Hoffer L; Betzi S; Feracci M; Tsvetkov P; Devred F; Collette Y; Morelli X; Ballester P; Pasquier E
    Mol Oncol; 2020 Dec; 14(12):3083-3099. PubMed ID: 33021050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro anti-tubulin effects of mebendazole and fenbendazole on canine glioma cells.
    Lai SR; Castello SA; Robinson AC; Koehler JW
    Vet Comp Oncol; 2017 Dec; 15(4):1445-1454. PubMed ID: 28078780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition.
    Yi JM; Zhang XF; Huan XJ; Song SS; Wang W; Tian QT; Sun YM; Chen Y; Ding J; Wang YQ; Yang CH; Miao ZH
    Oncotarget; 2015 Apr; 6(11):8960-73. PubMed ID: 25840421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model.
    Pinto LC; Soares BM; Pinheiro Jde J; Riggins GJ; Assumpção PP; Burbano RM; Montenegro RC
    Toxicol In Vitro; 2015 Dec; 29(8):2038-44. PubMed ID: 26315676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing: mebendazole as effective antitumor agent. Are we seeing the whole story?
    Banovic P; Stankov S; Vranjes N; Zurkovic O; Capo I; Lalosevic D
    J BUON; 2018; 23(6):1904-1911. PubMed ID: 30610820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model.
    Kang SH; Cho HT; Devi S; Zhang Z; Escuin D; Liang Z; Mao H; Brat DJ; Olson JJ; Simons JW; Lavallee TM; Giannakakou P; Van Meir EG; Shim H
    Cancer Res; 2006 Dec; 66(24):11991-7. PubMed ID: 17178898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma.
    Yung R; Seyfoddin V; Guise C; Tijono S; McGregor A; Connor B; Ching LM
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):639-49. PubMed ID: 24477604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
    Králová V; Hanušová V; Staňková P; Knoppová K; Čáňová K; Skálová L
    Anticancer Drugs; 2013 Oct; 24(9):911-9. PubMed ID: 23884106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.
    Thompson J; George EO; Poquette CA; Cheshire PJ; Richmond LB; de Graaf SS; Ma M; Stewart CF; Houghton PJ
    Clin Cancer Res; 1999 Nov; 5(11):3617-31. PubMed ID: 10589779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer.
    Nygren P; Fryknäs M; Agerup B; Larsson R
    J Cancer Res Clin Oncol; 2013 Dec; 139(12):2133-40. PubMed ID: 24135855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin blocks brain tumor formation.
    Purkayastha S; Berliner A; Fernando SS; Ranasinghe B; Ray I; Tariq H; Banerjee P
    Brain Res; 2009 Apr; 1266():130-8. PubMed ID: 19368804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repositioning from bench to bedside: tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer.
    Nygren P; Larsson R
    Acta Oncol; 2014 Mar; 53(3):427-8. PubMed ID: 24160353
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.
    Liu PY; Sokolowski N; Guo ST; Siddiqi F; Atmadibrata B; Telfer TJ; Sun Y; Zhang L; Yu D; Mccarroll J; Liu B; Yang RH; Guo XY; Tee AE; Itoh K; Wang J; Kavallaris M; Haber M; Norris MD; Cheung BB; Byrne JA; Ziegler DS; Marshall GM; Dinger ME; Codd R; Zhang XD; Liu T
    Oncotarget; 2016 Nov; 7(48):79217-79232. PubMed ID: 27764794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.